Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Russia Turns The Screw On Foreign-Made Drugs

This article was originally published in Scrip

Executive Summary

Pharmaceutical firms operating in Russia and some of its neighbouring countries might want to cast an eye over their local manufacturing strategy after the government imposed new restrictions on state purchases of foreign-made essential medicines.